| 07/08/2026 3:32 PM | Core Scientific (1839341) Issuer DUCHENE TODD M (1248745) Reporting | Form 4 Statement of changes in beneficial ownership of securities | |
| 07/06/2026 3:45 PM | Core Scientific (1839341) Subject DUCHENE TODD M (1248745) Reporting | Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
| 07/01/2026 6:17 PM | Core Scientific (1839341) Issuer DUCHENE TODD M (1248745) Reporting | Form 4 Statement of changes in beneficial ownership of securities | |
| 07/01/2026 6:18 PM | Core Scientific (1839341) Issuer Sullivan Adam Taylor (1980208) Reporting | Form 4 Statement of changes in beneficial ownership of securities | |
| 06/24/2026 3:02 PM | Core Scientific (1839341) Issuer DUCHENE TODD M (1248745) Reporting | Form 4 Statement of changes in beneficial ownership of securities | |
| 06/10/2026 3:14 PM | Core Scientific (1839341) Issuer DUCHENE TODD M (1248745) Reporting | Form 4 Statement of changes in beneficial ownership of securities | |
| 05/28/2026 3:20 PM | Core Scientific (1839341) Issuer DUCHENE TODD M (1248745) Reporting | Form 4 Statement of changes in beneficial ownership of securities | |
| 05/26/2026 3:19 PM | Core Scientific (1839341) Subject JANE STREET GROUP, LLC (1595888) Filed by | Form SCHEDULE 13G | |
| 05/26/2026 3:02 PM | Core Scientific (1839341) Filer | Form 8-K Current report pursuant to Section 13 or 15(d) | |
| 05/20/2026 3:20 PM | Core Scientific (1839341) Issuer DUCHENE TODD M (1248745) Reporting | Form 4 Statement of changes in beneficial ownership of securities | |
| 05/15/2026 6:46 PM | Core Scientific (1839341) Subject Valiant Capital Management, L.P. (1452689) Filed by | Form SCHEDULE 13G/A | |
Get the Latest News and Ratings for CORZZ and Related Stocks Enter your email address below to receive the latest news and analysts' ratings for Core Scientific and its competitors with MarketBeat's FREE daily newsletter.
|
| 05/15/2026 3:49 PM | Citadel Securities GP LLC (1721695) Filed by Core Scientific (1839341) Subject | Form SCHEDULE 13G/A | |
| 05/15/2026 11:29 AM | Core Scientific (1839341) Subject SUSQUEHANNA SECURITIES, LLC (1446580) Filed by | Form SCHEDULE 13G/A | |
| 05/13/2026 3:06 PM | Core Scientific (1839341) Issuer DUCHENE TODD M (1248745) Reporting | Form 4 Statement of changes in beneficial ownership of securities | |
| 05/11/2026 3:03 PM | Core Scientific (1839341) Issuer Ray Jorge L. (2123780) Reporting | Form 3 Initial statement of beneficial ownership of securities | |
| 05/06/2026 3:54 PM | Core Scientific (1839341) Filer | Form 10-Q General form for quarterly reports under Section 13 or 15(d) | |
| 05/06/2026 3:15 PM | Core Scientific (1839341) Issuer DUCHENE TODD M (1248745) Reporting | Form 4 Statement of changes in beneficial ownership of securities | |
| 05/06/2026 3:02 PM | Core Scientific (1839341) Filer | Form 8-K Current report pursuant to Section 13 or 15(d) | |
| 05/06/2026 3:06 PM | Core Scientific (1839341) Filer | Form 8-K Current report pursuant to Section 13 or 15(d) | |
| 05/06/2026 6:52 AM | Core Scientific (1839341) Filer | Form 8-K Current report pursuant to Section 13 or 15(d) | |
| 04/29/2026 11:56 AM | Core Scientific (1839341) Subject VANGUARD PORTFOLIO MANAGEMENT LLC (2100121) Filed by | Form SCHEDULE 13G | |
| 04/27/2026 4:30 PM | Core Scientific (1839341) Filer | Form 8-K Current report pursuant to Section 13 or 15(d) | |
| 04/23/2026 7:59 PM | Core Scientific (1839341) Subject Two Seas Capital LP (1823138) Filed by | Form SCHEDULE 13D/A | |
| 04/22/2026 3:01 PM | Core Scientific (1839341) Issuer DUCHENE TODD M (1248745) Reporting | Form 4 Statement of changes in beneficial ownership of securities | |
| 04/21/2026 6:36 AM | Core Scientific (1839341) Filer | Form 8-K Current report pursuant to Section 13 or 15(d) | |
| 04/17/2026 8:50 PM | Core Scientific (1839341) Issuer Sullivan Adam Taylor (1980208) Reporting | Form 4 Statement of changes in beneficial ownership of securities | |
| 04/17/2026 8:50 PM | Core Scientific (1839341) Issuer DUCHENE TODD M (1248745) Reporting | Form 4 Statement of changes in beneficial ownership of securities | |
| 04/16/2026 7:35 PM | Core Scientific (1839341) Subject Two Seas Capital LP (1823138) Filed by | Form SCHEDULE 13D/A | |
| 04/15/2026 3:02 PM | Core Scientific (1839341) Issuer DUCHENE TODD M (1248745) Reporting | Form 4 Statement of changes in beneficial ownership of securities | |
| 04/08/2026 3:32 PM | Core Scientific (1839341) Issuer DUCHENE TODD M (1248745) Reporting | Form 4 Statement of changes in beneficial ownership of securities | |
| 04/02/2026 7:25 PM | Core Scientific (1839341) Issuer DUCHENE TODD M (1248745) Reporting | Form 4 Statement of changes in beneficial ownership of securities | |
| 04/02/2026 7:26 PM | Core Scientific (1839341) Issuer Sullivan Adam Taylor (1980208) Reporting | Form 4 Statement of changes in beneficial ownership of securities | |
| 04/01/2026 3:44 PM | Core Scientific (1839341) Subject DUCHENE TODD M (1248745) Reporting | Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
| 03/31/2026 3:59 PM | Core Scientific (1839341) Filer | Form DEFA14A | |
| 03/31/2026 4:01 PM | Core Scientific (1839341) Filer | Form ARS | |
| 03/31/2026 3:55 PM | Core Scientific (1839341) Filer | Form DEF 14A | |
| 03/27/2026 5:45 PM | Core Scientific (1839341) Issuer Nygaard James P Jr (1842273) Reporting | Form 4/A | |
| 03/26/2026 4:39 PM | Core Scientific (1839341) Subject VANGUARD GROUP INC (102909) Filed by | Form SCHEDULE 13G/A | |
| 03/23/2026 7:29 AM | Core Scientific (1839341) Filer | Form 8-K Current report pursuant to Section 13 or 15(d) | |
| 03/20/2026 7:39 PM | Core Scientific (1839341) Subject Two Seas Capital LP (1823138) Filed by | Form SCHEDULE 13D/A | |
| 03/19/2026 3:06 PM | Core Scientific (1839341) Issuer Nygaard James P Jr (1842273) Reporting | Form 4 Statement of changes in beneficial ownership of securities | |
Trump’s secret China deal (Ad) Trump just returned from Beijing with the most powerful business delegation in American history - Elon Musk, Jensen Huang, Tim Cook, and the CEOs of BlackRock, Goldman Sachs, and CitiBank. The media covered the handshakes. But what was really being negotiated behind closed doors?
Porter Stansberry has connected the Beijing trip to a landmark pact signed by 13 nations in Washington - a pact designed to cut China out of a $3 trillion investment wave tied to the most critical resource of the 21st century. His new documentary exposes the five assets at the center of it all. Watch the full documentary and see which assets are positioned to benefit |
| 03/18/2026 4:14 PM | Core Scientific (1839341) Filer | Form 10-K/A | |
| 03/12/2026 11:55 AM | Core Scientific (1839341) Subject Valiant Capital Management, L.P. (1452689) Filed by | Form SCHEDULE 13G | |
| 03/10/2026 3:08 PM | Core Scientific (1839341) Issuer Weiss Eric Stanton (2009491) Reporting | Form 4 Statement of changes in beneficial ownership of securities | |
| 03/06/2026 3:13 PM | Core Scientific (1839341) Filer | Form 8-K Current report pursuant to Section 13 or 15(d) | |
| 03/04/2026 8:05 PM | Core Scientific (1839341) Subject Two Seas Capital LP (1823138) Filed by | Form SCHEDULE 13D/A | |
| 03/02/2026 3:44 PM | Core Scientific (1839341) Filer | Form 10-Q/A | |
| 03/02/2026 3:18 PM | Core Scientific (1839341) Filer | Form 10-K/A | |
| 02/19/2026 8:17 PM | Core Scientific (1839341) Subject Two Seas Capital LP (1823138) Filed by | Form SCHEDULE 13D/A | |
| 02/19/2026 10:56 AM | Core Scientific (1839341) Filer | Form 8-K/A | |
| 02/18/2026 4:16 PM | Core Scientific (1839341) Filer | Form 8-K Current report pursuant to Section 13 or 15(d) | |
| 02/11/2026 10:11 AM | BARCLAYS PLC (312069) Filed by Core Scientific (1839341) Subject | Form SCHEDULE 13G/A | |
| 02/09/2026 5:08 PM | Core Scientific (1839341) Subject Valiant Capital Management, L.P. (1452689) Filed by | Form SCHEDULE 13G/A | |
| 02/06/2026 3:11 PM | Core Scientific (1839341) Issuer Weiss Eric Stanton (2009491) Reporting | Form 4 Statement of changes in beneficial ownership of securities | |
| 02/06/2026 3:11 PM | Core Scientific (1839341) Issuer Rozov Yadin (1921268) Reporting | Form 4 Statement of changes in beneficial ownership of securities | |
| 02/06/2026 3:11 PM | Core Scientific (1839341) Issuer CRAIN ELIZABETH (1604659) Reporting | Form 4 Statement of changes in beneficial ownership of securities | |
| 02/06/2026 3:11 PM | Core Scientific (1839341) Issuer Levy Jordan (1541436) Reporting | Form 4 Statement of changes in beneficial ownership of securities | |
| 02/06/2026 3:11 PM | Booth Jeffrey David (2009493) Reporting Core Scientific (1839341) Issuer | Form 4 Statement of changes in beneficial ownership of securities | |
| 01/26/2026 3:15 PM | Core Scientific (1839341) Issuer Sullivan Adam Taylor (1980208) Reporting | Form 4 Statement of changes in beneficial ownership of securities | |
| 01/20/2026 8:07 PM | Core Scientific (1839341) Subject Two Seas Capital LP (1823138) Filed by | Form SCHEDULE 13D/A | |
| 01/07/2026 1:59 PM | Core Scientific (1839341) Subject VANGUARD GROUP INC (102909) Filed by | Form SCHEDULE 13G/A | |
| 01/02/2026 5:26 PM | Core Scientific (1839341) Issuer Rozov Yadin (1921268) Reporting | Form 4 Statement of changes in beneficial ownership of securities | |
| 12/18/2025 7:17 PM | Core Scientific (1839341) Subject Two Seas Capital LP (1823138) Filed by | Form SCHEDULE 13D/A | |
| 12/10/2025 5:12 PM | Citadel Securities GP LLC (1721695) Filed by Core Scientific (1839341) Subject | Form SCHEDULE 13G | |
| 12/01/2025 7:04 PM | Core Scientific (1839341) Subject Two Seas Capital LP (1823138) Filed by | Form SCHEDULE 13D/A | |
| 11/17/2025 5:35 PM | Core Scientific (1839341) Subject Two Seas Capital LP (1823138) Filed by | Form SCHEDULE 13D/A | |
| 11/13/2025 4:42 PM | Core Scientific (1839341) Subject SUSQUEHANNA SECURITIES, LLC (1446580) Filed by | Form SCHEDULE 13G/A | |
| 11/12/2025 3:05 PM | BARCLAYS PLC (312069) Filed by Core Scientific (1839341) Subject | Form SCHEDULE 13G | |
| 11/03/2025 5:42 PM | Core Scientific (1839341) Subject | Form SCHEDULE 13G | |
| 11/03/2025 5:42 PM | Core Scientific (1839341) Subject Valiant Capital Management, L.P. (1452689) Filed by Valiant Capital Management, L.P. (1452689) Filed by | Form SCHEDULE 13G | |
| 10/31/2025 4:16 PM | Core Scientific (1839341) Subject Two Seas Capital LP (1823138) Filed by | Form SCHEDULE 13D/A | |
| 10/31/2025 3:27 PM | Core Scientific (1839341) Filer | Form 8-K Current report pursuant to Section 13 or 15(d) | |
| 10/30/2025 3:18 PM | Core Scientific (1839341) Filer | Form 8-K Current report pursuant to Section 13 or 15(d) | |
| 10/30/2025 9:55 AM | Core Scientific (1839341) Filer | Form 8-K Current report pursuant to Section 13 or 15(d) | |
| 10/30/2025 9:28 AM | Core Scientific (1839341) Filer | Form 8-K Current report pursuant to Section 13 or 15(d) | |
| 10/28/2025 4:00 PM | Core Scientific (1839341) Subject Two Seas Capital LP (1823138) Filed by | Form DFAN14A | |
| 10/24/2025 3:14 PM | Core Scientific (1839341) Filer | Form 10-Q General form for quarterly reports under Section 13 or 15(d) | |
| 10/24/2025 3:06 PM | Core Scientific (1839341) Filer | Form 8-K Current report pursuant to Section 13 or 15(d) | |
| 10/22/2025 4:20 PM | Core Scientific (1839341) Subject CoreWeave, Inc. (1769628) Filed by | Form 425 | |
| 10/22/2025 3:44 PM | Core Scientific (1839341) Filer | Form 8-K Current report pursuant to Section 13 or 15(d) | |
| 10/22/2025 3:44 PM | Core Scientific (1839341) Subject | Form 425 | |
| 10/21/2025 4:22 PM | Core Scientific (1839341) Subject Two Seas Capital LP (1823138) Filed by | Form DFAN14A | |
| 10/17/2025 4:00 PM | Core Scientific (1839341) Subject Two Seas Capital LP (1823138) Filed by | Form DFAN14A | |
| 10/17/2025 5:09 AM | Core Scientific (1839341) Subject CoreWeave, Inc. (1769628) Filed by | Form 425 | |
| 10/16/2025 4:22 PM | Core Scientific (1839341) Subject CoreWeave, Inc. (1769628) Filed by | Form 425 | |
| 10/15/2025 3:45 PM | Core Scientific (1839341) Filer | Form 8-K Current report pursuant to Section 13 or 15(d) | |
| 10/15/2025 3:48 PM | Core Scientific (1839341) Subject | Form 425 | |
| 10/14/2025 4:50 PM | Core Scientific (1839341) Subject Situational Awareness LP (2045724) Filed by | Form SCHEDULE 13D/A | |
| 10/14/2025 7:30 AM | Core Scientific (1839341) Subject Two Seas Capital LP (1823138) Filed by | Form DFAN14A | |
| 10/10/2025 7:48 PM | Core Scientific (1839341) Filer | Form 8-K Current report pursuant to Section 13 or 15(d) | |
| 10/10/2025 7:55 PM | Core Scientific (1839341) Subject | Form 425 | |
Trump’s secret China deal (Ad) Trump just returned from Beijing with the most powerful business delegation in American history - Elon Musk, Jensen Huang, Tim Cook, and the CEOs of BlackRock, Goldman Sachs, and CitiBank. The media covered the handshakes. But what was really being negotiated behind closed doors?
Porter Stansberry has connected the Beijing trip to a landmark pact signed by 13 nations in Washington - a pact designed to cut China out of a $3 trillion investment wave tied to the most critical resource of the 21st century. His new documentary exposes the five assets at the center of it all. Watch the full documentary and see which assets are positioned to benefit |
| 10/10/2025 4:27 PM | Core Scientific (1839341) Subject Two Seas Capital LP (1823138) Filed by | Form DFAN14A | |
| 10/10/2025 4:02 PM | Core Scientific (1839341) Subject CoreWeave, Inc. (1769628) Filed by | Form 425 | |
| 10/09/2025 6:39 PM | Core Scientific (1839341) Subject Two Seas Capital LP (1823138) Filed by | Form SCHEDULE 13D/A | |
| 10/07/2025 4:27 PM | Core Scientific (1839341) Subject CoreWeave, Inc. (1769628) Filed by | Form 425 | |
| 10/07/2025 4:27 PM | Core Scientific (1839341) Subject CoreWeave, Inc. (1769628) Filed by | Form 425 | |
| 10/07/2025 4:23 PM | Core Scientific (1839341) Subject CoreWeave, Inc. (1769628) Filed by | Form 425 | |
| 10/07/2025 4:24 PM | Core Scientific (1839341) Subject CoreWeave, Inc. (1769628) Filed by | Form 425 | |
| 09/29/2025 9:06 AM | Core Scientific (1839341) Subject Two Seas Capital LP (1823138) Filed by | Form DFAN14A | |
| 09/29/2025 7:00 AM | Core Scientific (1839341) Subject Two Seas Capital LP (1823138) Filed by | Form DEFC14A | |